ASX:PABINVESTOR PRESENTATION · OCTOBER 2026B rid g in g G ap s in T h erap eu tic C areDeveloping the potential first treatment for delirium approved broadlyIn the clinicKnown moleculeFDA 505(b)(2) pathwayGlobal unmet needpatrys.comDisclaimerPatrys Limited...
Investor Presentation
Filed with ASX · · 17 pages · English
Release
Earlier from Patrys
- Investor Webinar
- Date of AGM and Closing Date for Director Nominations
- Notification of cessation of securities - PAB
- Patrys Completes Cohort 1 Dosing and Follow-Up
- Appendix 4E Variance Report
Later from Patrys
- RLS-2202 Phase 1a Trial Advances to Cohort 2
- Appendix 4C - Quarterly - 30 September 2026
- Notice of Annual General Meeting/Proxy Form
- Letter to Shareholders - Annual General Meeting
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys